The relationship between insulin resistance and inflammation indicates that inflammation negatively impacts the PI-3 K/Akt signaling pathway, which is responsible for the production of NO, ultimately leading to a decrease in NO bioavailability (42). This evidence concerns the gene AKT1 and Insulin resistance.